The U.S. National Nuclear Security Administration (NNSA) is carrying through with a pledge made earlier this year to provide $40 million more to support development of domestic commercial production of the medical isotope molybdenum-99.
The aim of the semiautonomous…
SUBSCRIBER ACCESS
Thank you for visiting
Nuclear Security & Deterrence Monitor!
You must be logged in as a subscriber to view this page.







